Alvotech (ALVO)
14.19
+0.61
(+4.49%)
USD |
NASDAQ |
May 24, 16:00
14.18
-0.01
(-0.07%)
After-Hours: 20:00
Alvotech Cash from Financing (Quarterly): 133.18M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 133.18M |
| December 31, 2023 | 20.66M |
| September 30, 2023 | 136.20M |
| June 30, 2023 | -2.732M |
| March 31, 2023 | 147.19M |
| Date | Value |
|---|---|
| December 31, 2022 | 128.37M |
| September 30, 2022 | 3.002M |
| June 30, 2022 | 239.17M |
| March 31, 2022 | 54.36M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.732M
Minimum
Jun 2023
239.17M
Maximum
Jun 2022
95.49M
Average
128.37M
Median
Dec 2022
Cash from Financing (Quarterly) Benchmarks
| AbbVie Inc | 10.82B |
| Teva Pharmaceutical Industries Ltd | -151.00M |
| Moolec Science SA | 4.82M |
| Procaps Group SA | -29.88M |
| NeuroMetrix Inc | 1.471M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -75.40M |
| Cash from Investing (Quarterly) | -3.48M |
| Free Cash Flow | -338.67M |
| Free Cash Flow Per Share (Quarterly) | -0.3256 |
| Free Cash Flow to Equity (Quarterly) | -98.00M |
| Free Cash Flow to Firm (Quarterly) | 98.02M |
| Free Cash Flow Yield | -9.82% |